|
International News Gates Foundation, Canadian Government Announce Joint Initiative to Develop HIV/AIDS VaccineFebruary 21, 2007 Bill Gates, co-founder of the Bill & Melinda Gates Foundation, and Canadian Prime Minister Stephen Harper on Tuesday announced a joint $139 million initiative to establish a research institute for the development of an HIV/AIDS vaccine, Toronto's Globe and Mail reports. According to the Globe and Mail, the Canadian government will provide about $111 million over five years and the Gates Foundation will provide $28 million to the initiative, called the Canadian HIV Vaccine Initiative (Galloway, Globe and Mail, 2/21). The initiative aims to develop a preventive HIV/AIDS vaccine within 10 years and will build a research facility to support Canadian scientists and other researchers worldwide (Duff-Brown, AP/South Florida Sun-Sentinel, 2/21). According to the Globe and Mail, the funding will be used to develop vaccine candidates and bolster the ability to run clinical trials (Globe and Mail, 2/21). The research facility will be the first in the world with the production capacity to manufacture experimental vaccines for clinical trials, the AP/Sun-Sentinel reports. The Canadian government will accept proposals from provinces interested in hosting the facility, according to a spokesperson for Canadian Health Minister Tony Clement. According to Gates, the initiative will run under the Global HIV Vaccine Enterprise (AP/South Florida Sun-Sentinel, 2/21). Reaction Back to other news for February 21, 2007
Reprinted with permission from kaisernetwork.org. You can view the entire Kaiser Daily HIV/AIDS Report, search the archives, or sign up for email delivery at www.kaisernetwork.org/dailyreports/hiv. The Kaiser Daily HIV/AIDS Report is published for kaisernetwork.org, a free service of the Kaiser Family Foundation, by The Advisory Board Company. © 2007 by The Advisory Board Company and Kaiser Family Foundation. All rights reserved. This article was provided by Henry J. Kaiser Family Foundation. It is a part of the publication Kaiser Daily HIV/AIDS Report. Visit the Kaiser Family Foundation's website to find out more about their activities, publications and services.
|
|